University of Southern Florida

Tampa, Florida 33620

2 studies enrolling now · 6 studies all time

What they study most

Carnitine Palmitoyltransferase (CPT II) Deficiency, Developmental and Epileptic Encephalopathies, Dravet Syndrome, Hemophilia A, Lennox Gastaut Syndrome, Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency, Parkinson Disease, Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), Trifunctional Protein (TFP) Deficiency, Vertebral Artery Stenosis, Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency

Studies at this site

• Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER) — Recruiting now
• Intermediate-Size Expanded Access Protocol (EAP) for LP352 — Available (expanded access)
• ADVATE Post Authorization Safety Surveillance — Completed
• A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) — Completed
• Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) — Stopped early
• A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) — Completed